Opposite regulation of estrogen receptor-α and its variant ER-α36 by the Wilms' tumor suppressor WT1.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Oncology Letters

• Publication date

  2011-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/OL.2011.250PMID 22737185PMCID PMC3380379
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Wilms' tumor suppressor WT1 induces estrogen-independent growth and anti-estrogen insensitivity in ER-positive breast cancer MCF7 cells.

  2010cited by this paper
• Estrogen receptor‐alpha (ER‐α) suppresses expression of its variant ER‐α36

  2009cited by this paper
• Expression of ER- 36, a Novel Variant of Estrogen Receptor , and Resistance to Tamoxifen Treatment in Breast Cancer

  2009cited by this paper
• Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.

  2009cited by this paper
• ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas.

  2008cited by this paper
• ER-α36, a Novel Variant of ER-α, is Expressed in ER-positive and -negative Human Breast Carcinomas

  2008cited by this paper
• Wilms' Tumor 1 Suppressor Gene Mediates Antiestrogen Resistance via Down-Regulation of Estrogen Receptor-α Expression in Breast Cancer Cells

  2008cited by this paper
• Isoforms of Wilms’ tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells

  2007cited by this paper
• A tumor suppressor and oncogene: the WT1 story

  2007cited by this paper
• Nature of functional estrogen receptors at the plasma membrane.

  2006cited by this paper
• A variant of estrogen receptor-α, hER-α36: Transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling

  2006cited by this paper
• A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.

  2006cited by this paper
• Integration of the extranuclear and nuclear actions of estrogen.

  2005cited by this paper
• Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66.

  2005cited by this paper
• Identification, cloning, and expression of human estrogen receptor-α36, a novel variant of human estrogen receptor-α66

  2005cited by this paper
• Transcriptional activation of c-myc proto-oncogene by WT1 protein

  2004cited by this paper
• Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers

  2002cited by this paper
• High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients.

  2002cited by this paper
• Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes.

  2002cited by this paper
• Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling.

  2002cited by this paper
• Mechanisms of estrogen action.

  2001influential reference
• Rapid actions of plasma membrane estrogen receptors.

  2001cited by this paper
• Wilms tumor and the WT1 gene.

  2001cited by this paper
• Estrogen receptor interaction with estrogen response elements.

  2001influential reference
• Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.

  2001cited by this paper
• The Wilms' Tumor Gene Product WT1 Mediates the Down-regulation of the Rat Epidermal Growth Factor Receptor by Nerve Growth Factor in PC12 Cells*

  2001cited by this paper
• Wilms' tumor and the WT1 gene.

  1999cited by this paper
• A clinical overview of WT1 gene mutations

  1997cited by this paper
• Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia.

  1997cited by this paper
• Altered expression of the WT1 wilms tumor suppressor gene in human breast cancer.

  1997cited by this paper
• WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis.

  1995cited by this paper
• Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.

  1995cited by this paper
• The role of WT1 in Wilms tumorigenesis

  1993cited by this paper
• The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains.

  1993cited by this paper
• Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

  1990cited by this paper
• Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.

  1990cited by this paper
• Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts.

  1990cited by this paper
• Breast cancer: Epidemiology, endocrinology, biochemistry, and pathobiology

  1980cited by this paper
• Reproductive Biology and Endocrinology Open Access a Novel Variant of Er-alpha, Er-alpha36 Mediates Testosterone-stimulated Erk and Akt Activation in Endometrial Cancer Hec1a Cells

  year unknowncited by this paper

• Dynamic methylation and expression of alternative promoters for oestrogen receptor alpha in cell line models of fulvestrant resistance

  2024cites this paper
• Icariin, a phytoestrogen, exerts rapid estrogenic actions through crosstalk of estrogen receptors in osteoblasts

  2023cites this paper
• Estrogen receptor variant ER‐α36 facilitates estrogen signaling via EGFR in glioblastoma

  2022cites this paper
• The Role of ERα36 in Development and Tumor Malignancy

  2020cites this paper
• Plant Flavone Apigenin: an Emerging Anticancer Agent

  2017cites this paper
• Significant decline in anticancer immune capacity during puberty in the Tasmanian devil

  2017cites this paper
• ERα36--Another piece of the estrogen puzzle.

  2015influential citation
• Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer

  2015cites this paper
• High ERα36 Expression Level and Membrane Location Predict Poor Prognosis in Renal Cell Carcinoma

  2015cites this paper
• Predicting survival for multiple myeloma patients using baseline neutrophil/lymphocyte ratio

  2014cites this paper
• ER-α36: a novel biomarker and potential therapeutic target in breast cancer

  2014cites this paper
• The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors

  2014cites this paper
• Astrocyte elevated gene-1 activates MMP9 to increase invasiveness of colorectal cancer

  2014cites this paper
• Prognostic significance of TMEM16A, PPFIA1, and FADD expression in invasive ductal carcinoma of the breast

  2014cites this paper
• Surgical Management of Intraabdominal Metastases From Melanoma: Role of the Neutrophil to Lymphocyte Ratio as a Potential Prognostic Factor

  2014cites this paper
• eR- α 36: a novel biomarker and potential therapeutic target in breast cancer

  2014cites this paper
• Neutrophil to Lymphocyte Ratio May Predict Mortality in Breast Cancer Patients

  2013cites this paper
• Apigenin Induces Apoptosis and Blocks Growth of Medroxyprogesterone Acetate-Dependent BT-474 Xenograft Tumors

  2012cites this paper